FOR RESEARCH & CLINICAL TRIALS

RESP® Biosensor

Digital respiratory endpoints and cough monitoring for life sciences

FDA 510(k) Class II | CE Mark | HIPAA Compliant

Cough Monitor - RESP Biosensor

Technology Overview

The RESP® Biosensor is a first-of-its-kind respiratory wearable developed to capture novel insights into treatment effects, including changes in cough frequency and lung sounds such as wheeze.

  • Patient-Friendly: A wireless, discreet form factor that respects patient comfort in daily life
  • Multi-Parameter: Collects a robust combination of respiratory and physiological measurements 
  • Validated Reporting: Our qualified and trained annotation team ensures reporting meets endpoint requirements
RESP Cough Monitoring System

RESP® Biosensor Measures

Cough Monitoring
          • Cough Frequency (24-hour)
          • Cough Intensity* & Bouts
          • All Lung Sounds 
          • Wheeze
          • Rhonchi
          • Crackles
          • Breathing Patterns & Respiratory Rate*
          • Heart Rate & Heart Rate Variability*
          • Orientation*
          • Sleep/Wake*
          • Activity Levels*

*Measurement not FDA cleared but may be collected in clinical trials

Trusted By

Metrics-at-a-Glance

1M+

Lung Sounds Captured

30M+

Breaths Captured

32

Countries

35
Languages
2
FDA 510(K) clearances
1
CE Mark

Why the RESP® Biosensor System?

Privacy & Security

Incorporates end-to-end encryption and speech obfuscation to preserve patient privacy

Accelerated Data Turnaround

Cloud-based, remote syncs streamline subject reporting and enable real-time adherence insights 

High Fidelity & Integrity

Clinically validated, FDA 510(k) class II medical device that accurately collects data in real-world environments

Patient-Friendly

Wireless, discreet biosensor designed to integrate seamlessly into daily life

Multi-Dimensional Data

Collects a robust combination of respiratory and physiological data, all in one device

More Than a Cough Monitor

Using a combination of audio and motion data, the RESP Biosensor unlocks valuable insight across multiple indications, offering a more complete picture of subjects’ respiratory status and health-related quality of life alongside PROs.

Cough Wheeze Crackles Respiratory Rate* Heart Rate* Activity Level* Orientation*
Chronic Cough
IPF
Bronchitis
COPD
Asthma
RSV
Covid-19
Heart Failure
  • Chronic Cough
  • IPF
  • Bronchitis
  • COPD
  • Asthma
  • RSV
  • Covid-19
  • Heart Failure

*Measurement not FDA cleared but may be collected in clinical trials

Flexible Reporting—Automated or Human Annotation

Strados RESP biosensor data
  • Strados Labs’ trained and qualified annotation team identifies and counts cough and lung sounds from subject recordings to meet primary endpoint requirements. 
  • Our CoughCheck machine learning algorithm*, trained on over 200,000 coughs, has demonstrated strong accuracy in cough detection and is available for applications such as high-volume screening or exploratory endpoints.

*Algorithm not FDA-cleared but may be used in clinical trials

Visual spectrograms of lung sound events facilitate overread for trained annotators

Cough

Wheeze

Crackles

Cough Monitor - RESP

Patient-Friendly Form Factor

  • Unobtrusive, wireless form factor reduces patient burden in clinical trials.
  • 3M Tegaderm dressing, gentle and breathable, is used to adhere biosensor to chest
  • Discreet design helps ensure patients behave naturally, capturing authentic symptom data that mirrors real-life conditions and minimizes the Hawthorne effect.

Publications

View our clinical validation, whitepapers and case studies

Stepwise Validation Program

Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough

Poster Presentation, American Thoracic Society, 2025

Objective Cough Monitoring
Objective Cough Monitoring Detects More Patients with Cough Than Patient Self-Reporting

Poster Presentation, American Cough Conference, 2023

Results of Clinical performance testing in Chronic lung diseases
Results of Clinical Performance Testing in Chronic Lung Diseases

Poster Presentation, American Thoracic Society, 2022

Talk to our Team

Explore using the RESP® Biosensor in your next study